2C-D

GPTKB entity

Statements (33)
Predicate Object
gptkbp:instanceOf amphetamine
Hallucinogen
gptkbp:category recreational drug
psychedelic phenethylamine
substituted phenethylamine
gptkbp:chemicalFormula C10H15NO2
gptkbp:discoveredBy gptkb:Alexander_Shulgin
gptkbp:duration_of_effects 4 to 6 hours
gptkbp:effect psychedelic
hallucinogenic
entactogenic
gptkbp:firstSynthesized 1970
gptkbp:hasSMILES CC1=CC(OC)=C(CCN)C=C1OC
https://www.w3.org/2000/01/rdf-schema#label 2C-D
gptkbp:IUPACName 2,5-dimethoxy-4-methylphenethylamine
gptkbp:legal_status_in_Canada Schedule III controlled substance
gptkbp:legal_status_in_Germany Anlage I controlled substance
gptkbp:legal_status_in_United_Kingdom Class A drug
gptkbp:legal_status_in_United_States Schedule I controlled substance
gptkbp:mentions gptkb:PiHKAL
gptkbp:molecularWeight 181.23 g/mol
gptkbp:otherName 2,5-dimethoxy-4-methylphenethylamine
2C-M
gptkbp:PubChem_CID 19132
gptkbp:relatedTo gptkb:2C-E
gptkb:2C-B
gptkb:2C-I
gptkbp:routeOfAdministration oral
insufflation
gptkbp:UNII 6Z6X5W1E3D
gptkbp:bfsParent gptkb:NBOMe_series
gptkb:2C_family
gptkbp:bfsLayer 7